Skip to content

All Science No Fiction

Are all liposomal supplements created equal?

Believe it or not, there is currently no standardisation or specific labelling requirements for liposomal manufacturers. This means, as a consumer, it can be difficult to know what you are actually buying.

Even the terminology can be misleading.

The word “liposomal” does not mean “liposome.” These terms are not one and the same, even though they sound similar. The term liposomal is widely being used simply to mean “containing fat”. So products containing just fat (lipid) and vitamin C mixed together are being termed as liposomal but without the presence of liposomes.

It's a minefield.

Identifying authentic liposomal supplements.

We have been analysing commercial liposomal supplements for the past seven years. To date, we have only found one other product on the market which displays most characteristics of a true, quality liposomal formula.

As recently as November 2021, the Advertising Standards Agency published a ruling on the marketing of liposomal supplements, following the analysis of a particular brand of “liposomal” Vitamin C.

This brand’s products were found to be devoid of any liposomes, despite having been heavily marketed as such since its launch in 2018. “Because we had not seen conclusive evidence confirming the presence of liposomes in [brand x] product, we concluded that the claims “liposomal vitamin C”, and similar claims about the liposomal nature of the product, had not been substantiated and were therefore misleading.”

With so many liposomal brands coming to market making efficacy claims that have little to no scientific proof to back them up, how can you identify an authentic liposomal supplement?

Asking the right questions is a good first step in understanding a quality product.  Creating effective liposomal delivery in food supplements is an exact science. The process and technology is complicated and involves intricate steps to ensure proper stability, potency, compatibility and consistency.

Below you can review the results of our liposomal characterisation analysis. Our aim is to give you, the consumer, an insight into the quality of liposomal products sold across the UK and Europe.

lipolife

Particle Size

In order for liposomes to be effectively and efficiently absorbed into the cells, they need to be a certain size.  If the liposome matrix is too large, it will not be absorbed and will instead be excreted. 
Ideally for liposomal Vitamin C, the particle size should be between 100nm and 200nm.

Some products fell within the range considered optimum for absorption. Several products contained liposomes over 400nm and one product completely lacked any liposomes, returning a false positive from a molecule of glycerol. 

lipolife

Polydispersity index (PDI)

PDI is a measure of the variability of a sample based on size.

A low PDI means a stable formula with higher absorption potential. A high PDI value will result in an unstable formula with lower absorption capability.

Our PDI analysis revealed a significant difference in quality. 

lipolife, highlighted, returned a PDI of 0.2, with only two other products returning similar results.  Products which were found to have a PDI above 0.7 indicate formulas that are unlikely to be manufactured to a high quality.

lipolife

Nutrient Assay

By law, supplements can contain up to 50% more or 20% less vitamin, and 45% more and 20% less mineral than what is stated on the label.

When analysing the Vitamin C content of the tested liposomal products, the majority fell into the acceptable parameters of the stated dose.

One particular product, a product which sells very well on a popular ecommerce platform, contained less than 4% of the stated Vitamin C content.

Marketing v Science

If you're researching the liposomal supplement market, you will have seen brands boasting claims like “10x absorption” or “95% absorption.”

Here’s the reality: absorption is not a fixed number - it is a variable dependent on the individual.

Rather than relying on misleading marketing statistics, which are seemingly plucked from obscurity, lipolife focus on the proven science of liposomal delivery and the meticulous quality control measures that ensure our liposomes are truly effective.

Our team of expert scientists have reviewed some of these claims made by liposomal brands.

A lot of the claims made are unsubstantiated, with little or no supportive scientific evidence.

Fact or Fiction?

Our mission - identify myths and misinformation and provide solid scientific “debunking” so you, the consumer, can separate science fact from science fiction.

Dry Liposomes: Debunking Misinformation with Real Science

In recent months, we’ve observed a concerning rise in misinformation about powdered (dry) liposomes, particularly within the food supplement industry.

Several contract manufacturers, often lacking true expertise in nanoencapsulation, have made claims such as:

  • “Only liquid liposomes preserve full integrity and function.”
  • “Turning liposomes into powder destroys their structure.”
  • “Liquid liposomes are the only ‘real’ liposomal delivery system.”

    These statements are not only misleading, they are scientifically inaccurate.
lipolife

Understanding Liposomes: Liquid vs. Dry

Liquid (wet) liposomes: Suspended in an aqueous solution, commonly used in drinkable supplements or softgels.

Dry liposomes: Created through freeze-drying (lyophilisation) or spray-drying, resulting in a shelf-stable powder that rehydrates in the body and reforms its vesicular structure.

lipolife

Why Dry Liposomes Are Scientifically Valid

When properly formulated with cryoprotectants (e.g., maltodextrin, acacia gum), dry liposomes retain their structure throughout drying, storage, and rehydration. Their functionality is preserved, and they reassemble into effective liposomes when ingested.

lipolife

Peer-Reviewed Evidence

  • Hussein et al., 2019: Spray-dried liposomes maintained integrity and controlled-release profile for oral delivery.
  • Omer et al., 2018: Demonstrated rehydration and performance of proliposome powders.
  • Chen et al., 2010: Reviewed cryoprotectants’ role in preserving liposomes during freeze-drying.
  • Crowe et al., 1984: Found trehalose prevents lipid fusion and leakage, stabilising dry liposomes.


These studies used advanced techniques such as Cryo-TEM, Dynamic Light Scattering (DLS) and encapsulation efficiency testing to confirm structural stability.

lipolife

Busting the Most Common Myths

Myth 1: “Only liquid liposomes are real liposomes.”

Fact: Liposomes are defined by structure, not physical state. Dry liposomes reform into vesicles upon hydration.

Myth 2: “Drying destroys the liposome structure.”

Fact: Poor formulation can degrade structure, but well-engineered dry liposomes retain full functionality.

Myth 3: “Powdered liposomes collapse into unstructured ingredients.”

Fact: Not when formulated correctly. With stabilisers like acacia, dry liposomes maintain their structure and reform on rehydration.

“The absence of ability or knowledge to make dry liposomes doesn’t mean they don’t exist.” Professor Mohammad Najlah, Chief Scientist, GMPriority Pharma

We work with academic researchers and invest in advanced nanoencapsulation R&D to ensure that every liposome, liquid or dry, is engineered to perform.
We formulate based on peer-reviewed data, not marketing trends. Our commitment is to transparency, efficacy, and integrity in every batch.

Our Scientists

The experts behind the encapsulation.

With over 35 years of combined expertise in liposomal encapsulation, the team behind lipolife® includes formulation scientists, researchers, medical doctors and PhDs, all dedicated to one goal: developing highly absorbable, clinically reliable supplements.

From raw material selection to finished product, we apply rigorous quality control at every stage, ensuring consistency, purity and performance.

CHIEF SCIENTIST

Professor Mohammad Najlah

BPharm, PgDip, PhD, FHEA, FRSC

Mohammad Najlah has been at the forefront of nano-encapsulation for over two decades.

He is a Professor of Pharmaceutics and Nanomedicine and Lead of the Pharmaceutical Research Group, part of Anglia Ruskin University’s Medical Technology Research Centre (MTRC). Mohammad obtained his PhD from the University of Manchester, focusing on the development of nano-medicines based on dendrimer prodrugs.

Professor Najlah was instrumental in developing ARU’s SuperLabs Complex, the establishment of a new undergraduate and postgraduate programmes and leading the Pharmaceutical Research Group.

PROF. MOHAMMAD NAJLAH